SEGMENT 1:

Joseph E. B. White, Esq. ,Senior President & C.E.O.,
Taxpayers Against Fraud

- Recent legislation greatly expanded the reach of the False Claims Act to reach modern fraud    schemes. What activities are now covered by the False Claims Act?
- The amended False Claims Act empowers the Government with an unparalleled investigative tool.    What is this fraud-fighting weapon and how can it be used?
- The recent Health Care Reform Bill weakened a traditional litigative defense for False Claims Act    defendants. What was this defense and how will this impact future cases?
- The Health Care Reform Bill provided additional resources to fight health care fraud. Why should all    health care providers pay special attention?
- Nearly $27 billion have been recovered under the False Claims Act in the last twenty-five years. Why    is this number just a drop in the bucket compared to the next 25 years?

SEGMENT 2:

Danielle Y. Conley q. ,Of Counsel.,
Wilmer Cutler Pickering Hale and Dorr

- The Obama Administration's recent enforcement initiatives to crack down on health care fraud. Specifically, I will discuss the Health Care Fraud Prevention and Enforcement Action Team, also known as “HEAT,” which is a senior-level joint task force of the Department of Justice and the Department of Health and Human Services. I'll address how the HEAT Strike Force Teams are changing the landscape of FCA investigations and how DOJ recoveries under the FCA are rising as a result of these new initiatives.
- The March 2010 rule change regarding Civil Investigative Demands, and how this change will affect government FCA investigations of corporations.
- FERA Amendments to the FCA. Specifically, I will discuss how these amendments significantly broaden liability under the FCA and strengthen protections for whistleblowers. I will focus on the amendments that have key implications for health care providers.

SEGMENT 3:

Kathleen McDermott . ,Partner,
Morgan, Lewis & Bockius LLP

- The False Claims Act has been amended in 2009 and 2010 in seminal reform legislation designed to support government anti-fraud initiatives and encourage the greater use of the private citizen qui tam provisions. The amendments have significantly changed the assessment of liability in certain types of cases and the strategies in defending investigations and litigation. A panel of nationally recognized False Claims Act practitioners will explain the seminal changes and offer perspective to litigation and compliance strategies, including:

          - 2010 Health Reform amendments to the False Claims Act and compare to 2009              amendments.
          - Increased exposure in health industry for overpayment and anti-kickback liability.
          - Expanded whistleblower jurisdiction to pursue False Claims Act cases.
          - Use of civil investigative demands (CID) and impact on False Claims Act investigations.
          - Recent federal cases on the False Claims Act – a judicial pushback to novel theories?

SEGMENT 4:

Robert K. Huffman,Partner,
Akin Gump Strauss Hauer & Felp, LLP`

1. Liability: The False Claims Act has broad applicability to all federal programs, and imposes liability     not only for intentional fraud, but also for "knowing" misconduct in connection with federal     programs.

2. Damages: The False Claims Act imposes treble damages and penalties, which can spell      tremendous potential monetary exposure in many situations.

3. Qui Tam enforcement: The False Claims Act is enforced not only by the Department of Justice, but     also by qui tam plaintiffs who are seeking a bounty. It is important for all entities participating in     federal programs to understand how the qui tam mechanism works.

4. Defending the Qui Tam Lawsuit: The principal tools in the defendant's toolkit to defeat qui tam     claims are Rule 9(b), the Public Disclosure bar, and the truth.

5. Avoiding FCA Liability: The best strategy is to have a strong compliance program, to avoid any     activity that might be viewed as violating the False Claims Act, and to take common-sense steps to     minimize the possibility of qui tam lawsuits.

SEGMENT 5:

Yvonne Craver,Partner,
Deloitte Financial Advisory Services LLP

· Understanding your exposure – many companies are now receiving federal dollars who have never   received them before – beware!
· Addressing overpayments – costs of knowingly retaining overpayments can be steep
· Agencies receiving additional resources for government fraud investigations, prosecutions, and civil   proceedings